{
  "id": 6154040,
  "title": "FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote",
  "url": "https://urgent.news/2026/09/07/fda-approves-astrazenecas-oral-serd-for-breast-cancer-despite",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-07T17:17:43.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/fda-approves-astrazenecas-oral-serd-for-breast-cancer-despite-negative-adcomm-vote/"
  },
  "original_language": "en",
  "account": null,
  "summary": "AstraZeneca clinched an FDA accelerated approval for its oral SERD in certain breast cancer patients Friday, even after a negative vote from the agency’s advisory committee in April. Camizestrant, with the brand ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}